Approximately 2.8 million people around the world are currently living with multiple sclerosis (MS), yet there is still no known cure for the disease. One reason MS is so hard to pin down is that it manifests differently in every person, causing various combinations of symptoms in some and remaining “clinically silent” in others even as the disease worsens…
At ViewMind, we’re finding new and better ways to diagnose and measure neurocognitive health. As part of this mission, we’ve been working to demystify the…
At ViewMind, we’re finding new and better ways to diagnose and measure neurocognitive health. As part of this mission, we’ve been working to demystify the…
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for thedetection of Alzheimer’s disease and how soon in the disease’s trajectory detection…
Digital biomarkers: Charting the unknown With Digital Health, the Future Is Now Amid the often dire news circulating this year, several outlets added a bit…
Apart from the horrifying statistic of more than six million deaths from COVID-19 worldwide, one of the most troubling outcomes of the disease has been…
Cognitive impairment is a multifaceted ailment that has long bedevilled researchers due to the unpredictable nature of its progression. Some individuals with mild cognitive impairment…
Alzheimer’s disease, the leading cause of dementia, is notoriously difficult to diagnose in its initial stages. This is one reason that numbers of Alzheimer’s cases…
Brain Health for Life
Easy to perform. Non-invasive.
Precision Neurology.
